Simplifying Global Compliance
Chinese Device Trial Guidelines Exempt ‘Equivalent’ Products
Clinical Trials Advisor
Devicemakers won’t have to stage new clinical trials of their devices to gain approval in China if they can demonstrate that they’re basically equivalent to devices already on the market, the Chinese regulators say.
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing